VERACYTE, INC. Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)
VERACYTE, INC. (VCYT) reported Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) of -$2.07 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-14.
Discontinued › Income Statement › Other Income
us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2016-03-14
- VERACYTE, INC. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2013-12-31 was $0.00.
- VERACYTE, INC. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2013-09-30 was $0.00.
- VERACYTE, INC. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2013-06-30 was -$1.07M.
- VERACYTE, INC. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2013-03-31 was -$1.00M.
- VERACYTE, INC. fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2013 was -$2.07M, a 844.60% decline from fiscal 2012.
- VERACYTE, INC. fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2012 was $278.00K, a 61.34% decline from fiscal 2011.
- VERACYTE, INC. fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2011 was $719.00K.
| Period end | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 3 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 6 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 9 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-14 | -$1.07M derived: sum of 3 quarters · filed 2016-03-14 | -$2.07M 10-K · filed 2016-03-14 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$1.07M derived: sum of 2 quarters · filed 2014-11-13 | -$2.07M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$2.07M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$1.00M 10-Q · filed 2014-05-09 | |||
| 2012-12-31 | $278.00K 10-K · filed 2015-03-25 | |||
| 2011-12-31 | $719.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |